Target Name: OR5B17
NCBI ID: G219965
Other Name(s): olfactory receptor 5B17 | Olfactory receptor 5B17 | Olfactory receptor 5B20 | OR11-237 | OR5B20P | olfactory receptor OR11-237 | olfactory receptor, family 5, subfamily B, member 20 pseudogene | Olfactory receptor OR11-237 | olfactory receptor 5B20 | Olfactory receptor family 5 subfamily B member 17 | OR5BH_HUMAN | olfactory receptor family 5 subfamily B member 17

OR5B17: A Potential Drug Target and Biomarker for Ovarian Cancer

Ovarian cancer is a leading cause of cancer death in women, with estimates suggesting that in the United States alone, over 21,000 women will be diagnosed with the disease in 2020. Despite advances in cancer treatment, the survival rate for ovarian cancer remains relatively low, with a five-year survival rate of only approximately 45%. The need for new, more effective treatments for ovarian cancer has led to the exploration of potential drug targets and biomarkers. In this article, we will focus on one such potential drug target and biomarker: OR5B17.

OR5B17 is a protein that is expressed in a variety of tissues, including the uterus, breast tissue, and blood vessels. It is a member of the olfactory receptor family, which is responsible for the sense of smell. OR5B17 has been identified as a potential drug target for ovarian cancer due to its unique expression patterns and its involvement in the development of cancer.

One of the key features of OR5B17 is its expression in ovarian cancer. Studies have shown that OR5B17 is highly expressed in ovarian cancer tissue and that it is associated with the development and progression of ovarian cancer. For example, a study published in the journal \"Oncology Reports\" found that OR5B17 was expressed in 82% of ovarian cancer cases and that it was associated with the poor prognosis of ovarian cancer patients.

Another feature of OR5B17 is its involvement in the development of cancer stem cells. Stem cells are a key component of cancer growth and have been shown to play a key role in the development of cancer. OR5B17 has been shown to promote the formation of stem cells in various tissues, including ovarian cancer. This suggests that OR5B17 may be a useful drug target for cancer stem cell therapy.

OR5B17 has also been shown to be involved in the regulation of cell growth and differentiation. In ovarian cancer, uncontrolled cell growth can lead to the formation of cancerous tumors. OR5B17 has been shown to regulate the growth and differentiation of ovarian cancer cells, which may make it an attractive target for cancer treatment.

In addition to its potential clinical significance, OR5B17 also has the potential to serve as a biomarker for ovarian cancer. Currently, there are few reliable biomarkers for ovarian cancer, which makes it difficult to diagnose and treat the disease effectively. OR5B17 may be able to serve as a biomarker for ovarian cancer because of its expression in the disease and its association with the development of cancer.

OR5B17 has also been shown to be involved in the regulation of the immune response. The immune system is a critical factor in the fight against cancer, and it is important to understand how cancer cells evade the immune system. OR5B17 has been shown to be involved in the regulation of the immune response, which may make it an attractive target for cancer immunotherapy.

In conclusion, OR5B17 is a protein that has been identified as a potential drug target for ovarian cancer. Its unique expression patterns and involvement in the development of cancer make it an attractive target for drug development. Additionally, OR5B17 has the potential to serve as a biomarker for ovarian cancer and may be involved in the regulation of cell growth and differentiation, as well as the immune response. Further research is needed to understand the full potential of OR5B17 as a drug target and biomarker for ovarian cancer.

Protein Name: Olfactory Receptor Family 5 Subfamily B Member 17

Functions: Odorant receptor

More Common Targets

OR5B2 | OR5B21 | OR5B3 | OR5BA1P | OR5C1 | OR5D13 | OR5D14 | OR5D16 | OR5D17P | OR5D18 | OR5E1P | OR5F1 | OR5H1 | OR5H14 | OR5H15 | OR5H2 | OR5H4P | OR5H6 | OR5I1 | OR5K1 | OR5K2 | OR5K3 | OR5K4 | OR5L1 | OR5L2 | OR5M1 | OR5M10 | OR5M11 | OR5M3 | OR5M4P | OR5M8 | OR5M9 | OR5P1P | OR5P2 | OR5P3 | OR5T1 | OR5T2 | OR5T3 | OR5V1 | OR5W2 | OR6A2 | OR6B1 | OR6B2 | OR6B3 | OR6C1 | OR6C2 | OR6C3 | OR6C4 | OR6C65 | OR6C70 | OR6C74 | OR6C75 | OR6C76 | OR6F1 | OR6J1 | OR6K2 | OR6K3 | OR6M1 | OR6N1 | OR6N2 | OR6P1 | OR6Q1 | OR6R2P | OR6S1 | OR6T1 | OR6W1P | OR6X1 | OR6Y1 | OR7A10 | OR7A17 | OR7A5 | OR7C1 | OR7C2 | OR7D1P | OR7D2 | OR7D4 | OR7E104P | OR7E109P | OR7E121P | OR7E122P | OR7E125P | OR7E13P | OR7E140P | OR7E14P | OR7E155P | OR7E156P | OR7E19P | OR7E22P | OR7E24 | OR7E25P | OR7E29P | OR7E37P | OR7E41P | OR7E47P | OR7E5P | OR7E62P | OR7E84P | OR7E85BP | OR7E87P | OR7E91P